A Study of Disease Prediction for NOTCH3

Overview

About this study

The purpose of this study is to assess NOTCH3-SVD disease progression and develop a disease prediction model using the NOTCH3-SVD staging system

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age >18 years
  • NOTCH3 cys variant
  • Minimum followup duration 20 months

Exclusion Criteria:

  • Individuals without NOTCH3 cys variant

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 12/26/2024. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

James Meschia, M.D.

Contact us for the latest status

Contact information:

Md Manjurul Islam Shourav M.B.B.S.

Shourav.MdManjurulIsl@mayo.edu

More information

Publications

Publications are currently not available